Sign in

CIK 0001812364 · Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
  1. 4 Open-market sale See remarks sold 247 shares at $2.84 ($701)
  2. 4 Planned sale Chief Financial Officer sold 4,864 shares at $2.84 ($13,814)
  3. 4 Open-market sale Chief Legal Officer sold 298 shares at $2.84 ($846)
  4. 144 Insider Sale of Securities
  5. SCHEDULE 13G Stake Statement of Beneficial Ownership
  6. S-8 Other Securities Offered to Employees in Benefit Plans
  7. 10-K Report Annual Report
  8. 8-K Event Results of operations
  9. 4 Open-market sale President and CEO sold 215,506 shares at an average $3.80 ($818,400)
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. 4 Open-market sale See remarks sold 45,464 shares at an average $4.50 ($204,753)
  12. 4 Planned sale Chief Financial Officer sold 58,936 shares at an average $4.55 ($268,339)
  13. 4 Open-market sale President, R&D sold 80,450 shares at an average $4.50 ($362,298)
  14. 4 Open-market sale Chief Legal Officer sold 54,479 shares at an average $4.55 ($247,872)
  15. 144 Insider Sale of Securities
  16. 144 Insider Sale of Securities
  17. 4 Planned sale President and CEO sold 375,000 shares at an average $4.70 ($1,762,500)
  18. 144 Insider Sale of Securities
  19. 144 Insider Sale of Securities
  20. 144 Insider Sale of Securities

Page 8 of 28 · 556 filings